were suspected of having a history of hemochromatosis based on abnormal values of serum ferritin >800 ng/mL; 69 had missing body mass index (BMI) data at baseline, and 18,660 had obese status (BMI ≥ 25 kg/m 2 ) at baseline. Because some participants had more than 1 exclusion criteria, the total number of men who were eligible for the study was 23,880. Of these, another 6,068 participants who did not attend any follow-up visits from 2006 to 2010 were additionally excluded. Eventually, 17,812 participants were enrolled for final analysis and observed for the development of obesity. The total follow-up period was 64,446.5 person-years, and the average follow-up period was 3.62 (standard deviation [SD], 1.44) person-years. Ethics approval for the study protocol and the data analysis were obtained from the institutional review board of Kangbuk Samsung Hospital. The informed consent requirement was exempted by the Institutional Review Board because researchers only accessed retrospectively a de-identified database for analysis purposes.
Clinical and laboratory measurements
Study data included a medical history, a physical examination, information provided by the questionnaire, and anthropometric and laboratory measurements. Subjects' medical and drug prescription histories were assessed by the examining physicians. All participants were asked to respond to a health-related behavior questionnaire on alcohol consumption, smoking, and exercise. The questions on alcohol intake included the frequency of alcohol consumption on a weekly basis and the general amount that was consumed on a daily basis (≥20 g/day). We considered people who reported that they smoked at the time of the questionnaire to be current smokers. In addition, participants were questioned on the weekly frequency of participation in physical activities that lasted long enough to produce perspiration such as jogging, bicycling, and swimming (≥1 time/week).
Diabetes mellitus was defined as fasting serum glucose level of at least 126 mg/dL, or the current use of blood glucose-lowering agents. Hypertension was defined as the current use of antihypertensive medication or as having a measured blood pressure ≥140/90 mmHg at initial examination. Trained nurses obtained sitting blood pressure levels using a standard mercury sphygmomanometer. The first and fifth Korotkoff sounds were used to measure the systolic and diastolic blood pressures, respectively. ity [12] [13] [14] . However, these studies were cross-sectional and were thus, unable to prove a temporal relationship.
Serum ferritin has been used as a surrogate variable to reflect body iron stores in healthy individuals [15] . In other words, a high level of serum ferritin represents a high level of iron accumulation in healthy individuals. However, some reports have shown that obesity is associated with iron deficiency [16] [17] [18] . Thus, the exact nature of the relationship between serum ferritin level and obesity remains unclear. Therefore, it is important to investigate the temporal relationship between elevated serum ferritin levels and obesity risk. To our knowledge, there have been no prospective studies on the relationship between serum ferritin levels at baseline and the development of obesity. Accordingly, we carried out a prospective study to evaluate the temporal relationship between serum ferritin levels at baseline and the risk of obesity; we also adjusted for those covariates that could increase the serum ferritin levels in Korean men.
Materials and Methods

Study design and data sources
A prospective cohort study was conducted to investigate the association between serum ferritin levels and the development of obesity. The study method has been previously described in detail [6] . Our study participants comprised Korean men undergoing a medical health check-up program at the Health Promotion Center of Kangbuk Samsung Hospital (Sungkyunkwan University, Seoul, Korea).
Study population
Our study participants comprised 46,787 men who visited the Health Promotion Center at Kangbuk Samsung Hospital for a medical check-up in 2005. Among the 46,787 participants, 23,646 were excluded for the following reasons: 2,224 had a positive serologic marker for hepatitis B surface antigen; 71 had a positive serologic marker for hepatitis C virus antibody; 51 were excluded for ultrasonographically detected liver cirrhosis; 445 for ultrasonographically detected chronic hepatic disease; 743 had a serum alanine aminotransferase (ALT) level higher than 100 U/L; 203 had a serum aspartate aminotransferase (AST) level higher than 100 U/L; 1,694 had a past history of blood transfusion; 239 had a past history of including malignancy; 324 had a past history of cardiovascular disease; 3,247 were receiving medication for lipid-lowering agents;
One-way ANOVA and chi-square test were used to analyze statistical differences among the characteristics of the study participants at the time of enrollment in relation to the quartile groups of serum ferritin levels. Categories of serum ferritin comprised the following quartiles: <67.2, 67.2-96.9, 96.9-138.1, and ≥138.1 mg/dL. The distributions of continuous variables were evaluated, and log transformations were used in the analysis as required.
For incident obesity cases, the time of obesity occurrence was assumed to be the midpoint between the visit during which obesity was first diagnosed and the baseline visit (2005). Person-years were calculated as the sum of follow-up times from the baseline until an assumed time of obesity development or until the final examination of each individual. The Cox-proportional hazard models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CI) for incident obesity when comparing the 3 highest quartiles of serum ferritin levels at baseline with the lowest quartile. In addition, data were adjusted for multiple covariates. We included variables that might confound the relationship between the serum ferritin levels and obesity in multivariable models, such as age, WBC, HOMA-IR, serum creatinine, TIBC, current smoking status, regular exercise, alcohol intake, hypertension, and diabetes mellitus. The linear trends of risks were tested by considering quartile number as a continuous variable.
To test the validity of the Cox-proportional hazard models, we checked the assumption that there are additive effects on the log-log scale, by using log-log survival curves. Two approaches were used to assess the validity of the Cox-proportional hazard models. First, the assumption was assessed by log-log survival curves and found to hold graphically. Second, time-dependent covariate analysis was used to confirm the validity. The time-dependent covariate was not statistically significant, which suggested that the validities of the Coxproportional models are not violated (obesity, P = 0.167; severe obesity, P = 0.105; WC-defined obesity, P = 0.147). Statistical significance was considered as P values <0.05. Statistical analyses were performed by using SAS 9.2 for Windows (SAS Institute, Cary, NC, USA).
results
During 64,446.5 person-years of follow-up from 2006 to 2010, 2,627 (14.9%) incident cases of obesity Blood samples were drawn from an antecubital vein after more than 12 hour of fasting. Serum levels of AST, ALT, and γ-glutamyltransferase (GGT) were measured using Bayer Reagent Packs (Bayer HealthCare, Tarrytown, NY, USA) on an automated chemistry analyzer (ADVIA 1650 Autoanalyzer; Bayer Diagnostics, Leverkusen, Germany). Insulin levels were measured with immunoradiometric assays (Biosource, Nivelles, Belgium). Insulin resistance was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR) as described by Matthews et al. as follows: fasting serum insulin (μU/mL) × fasting serum glucose (mg/dL)/22.5 [19] . Serum creatinine level was measured using the alkaline picrate (Jaffe) method, and fasting serum glucose level was measured using the hexokinase method. Total cholesterol and triglyceride levels were assessed using enzymatic colorimetric tests, while low-density lipoprotein cholesterol level was measured using the homogeneous enzymatic colorimetric test. We also measured high-density lipoprotein cholesterol level with the selective inhibition method (Bayer Diagnostics, Germany). Serum levels of ferritin and iron, and the total iron binding capacity (TIBC) were measured by electrochemiluminescence immunoassay using a Modular E170 analyzer (Roche Diagnostics, Basel, Switzerland).
Outcomes: BMI and waist circumference (WC)
Study data included a medical history, a physical examination, information provided by the questionnaire, and anthropometric and laboratory measurements [6] . The primary outcome was obesity; this was defined as a BMI ≥ 25 kg/m 2 . The secondary outcomes were severe obesity and abdominal obesity based on the waist circumference (WC). We defined severe obesity as a BMI of ≥ 30 kg/m 2 and abdominal obesity was defined as WC of >90 cm in accordance with the WHO guidelines for Asian populations [20] . Height and weight were measured after overnight fasting with participants shoeless and wearing a lightweight hospital gown. BMI was calculated as weight (kg) divided by the square of the height (m). Waist circumference was measured in the standing position, at the level of the umbilicus by a single examiner.
Statistical analysis
Data were expressed as means ± (standard deviation) or medians (interquartile range) for continuous variables and as percentages for categorical variables.
At baseline, the mean (SD) age of the study subjects was 42.9 (7.5) years and the median (interquartile range) of serum ferritin level was 97.0 mg/dL (67.2-138.1). A clear dose-response relationship was observed between all of the variables listed in the table and the serum ferritin quartile groups except for in the cases of serum creatinine and current smoking status.
developed. Compared with the analytic cohort (n = 17,812), the 6,068 participants excluded from the analytic cohort were 3.3 years older (46.2 vs. 42.9 years) and had less favorable metabolic profiles at baseline (See Supplemental Data Table 1 ).
The baseline characteristics of the study subjects by serum ferritin quartile group are presented in Table 1 . † Alcohol intake group was defined as the people who consumed the alcohol once a week or consumed the typical amount of alcohol once a day (≥20 g/day). ‡ Regular exercise group was defined as the people that responded who did a physical activity more than once a week (≥1 time/week).
and fourth baseline serum ferritin quartile groups compared with the first group of 1.08 (95% CI, 0.95-1.23), 1.14 (95% CI, 1.00-1.30), and 1.24 (95% CI, 1.09-1.41), respectively (P for trend = 0.003). Furthermore, the analyses were repeated for severe obesity (BMI ≥ 30 kg/m 2 ) and obesity based on WC (WC > 90 cm); the above-mentioned associations were found to be strengthened (Tables 3, 4 ).
Discussion
In this study, we found that elevation of serum ferritin levels at baseline was positively and significantly associated with the development of obesity over 5 years of follow-up in a large study cohort of initially non-obese Korean men. Since our data were relevant for time-to-event, we used the Cox-proportional model to estimate HRs for the risk of obesity development. These results provide novel evidence of a significant Participants who experienced incident obesity were slightly younger than those who did not experience incident obesity (42.4 vs. 43.0 years) and generally had less favorable metabolic profiles at baseline (See Supplemental Data Table 2 ). Table 2 shows the estimated HRs and 95% confidence intervals for incident obesity by the serum ferritin quartile groups using the Cox-proportional model. In the unadjusted model, the HRs for incident obesity for the second, third, and fourth quartiles versus the first quartile were 1.05 (95% CI, 0.93-1.17), 1.13 (95% CI, 1.01-1.27), and 1.29 (95% CI, 1.16-1.44), respectively (P for trend <0.001). Furthermore, these associations remained significant even after adjusting for covariates (models 1, 2, and 3). Model 3, which was adjusted for age, WBC, HOMA-IR, serum creatinine, TIBC, current smoking status, regular exercise, alcohol intake, hypertension, and diabetes mellitus, yielded adjusted HRs for incident obesity for the second, third, ‡ The reference group for the regular exercise is the people that responded who did a physical activity less than once a week (<1 time/week).
§ Alcohol intake group was defined as the people who consumed the alcohol once a week or consumed the typical amount of alcohol once a day (≥20 g/day). ‡ The reference group for the regular exercise is the people that responded who did a physical activity less than once a week (<1 time/week).
§ Alcohol intake group was defined as the people who consumed the alcohol once a week or consumed the typical amount of alcohol once a day (≥20 g/day). Table 4 Hazard ratios (HRs) and 95% confidence intervals (CI)* for the incidence of obesity based on the waist circumference (WC >90cm) according to quartile groups of serum ferritin levels.
Hazard ratios (95% Confidence Interval) was adjusted for model plus current smoking status, regular exercise and alcohol intake. Model 3 was adjusted for model 2 plus hypertension and diabetes mellitus. * Hazard ratios and 95% confidence intervals were obtained by the Cox-proportional hazard model. † The reference group for the smoking status is ex-smokers and non-smokers.
‡ The reference group for the regular exercise is the people that responded who did a physical activity less than once a week (<1 time/week).
§ Alcohol intake group was defined as the people who consumed the alcohol once a week or consumed the typical amount of alcohol once a day (≥20 g/day).
et al. demonstrated that increased serum ferritin levels, which reflect the body iron levels, have a causal association with the adipocytes that regulate metabolism independently through adiponectin expression via FOXO-1 deacetylation [29] .
In addition, mice fed a high-fat and high-fructose diet which was showed a significantly increased iron deposit in the liver in vivo study [30] . And hepatic free fatty acid, triglyceride and total cholesterol was also significantly increased in mice fed a high-fat and highfructose compared with normal mice [30] . In addition, a Japan Study Group of Nonalcoholic Fatty Liver Disease reported that serum ferritin level is one of main factors which can predict nonalcoholic steatohepatitis (NASH) in Japanese non-alcoholic fatty liver disease (NAFLD) patients [31] . An excessive ferrous and ferritin may induce the oxidative stress by provoked the Fenton reaction [32] . The oxidative stress which was provoked by excessive ferrous and ferritin may be a cause for the cell death and fibrosis [32] . This previous study showed that unhealthy diet, as high fat and energy intake have been associated with increased ferritin level and increased risk of fatty liver disease and obesity. Although we did not collect the diet behavior of participants, it was well-known that change in dietary pattern could influence the absorption of iron. Therefore, it is reasonable inference that elevated serum ferritin level may reflect unhealthy dietary pattern, like increase in consumption of meat.
In this study, we demonstrated that the serum ferritin level could be a predictive factor for obesity in the general population. We showed that the elevated serum ferritin level preceded obesity and had a doseresponse relationship. The dose-response relationship between serum ferritin level and obesity was also consistent when the outcome variables were severe obesity (BMI ≥ 30 kg/m 2 ) and WC (WC >90 cm). Some limitations should be considered when interpreting our results. First, bias from follow-up loss may have affected our results. The participants not included in the analysis (n = 6,068) were older and had less favorable metabolic profiles at baseline than those in the analytic cohort. This follow-up loss would probably have caused a conservative bias and subsequent underestimation of risk due to what could have been a higher proportion of high-risk participants. Second, participants were self-selected; thus, this study may show participant selection bias. Third, this study was restricted to men to eliminate the influence of pregindependent association between serum ferritin levels and obesity development. Furthermore, the estimated HRs for severe obesity (BMI ≥ 30 kg/m 2 ) and abdominal obesity (WC >90 cm) attributable to serum ferritin levels were much higher than that for obesity (BMI ≥ 25 kg/m 2 ). These associations also remained when subjects with DM or hypertension at baseline were excluded (data not shown).
To our knowledge, to date, there have only been 3 studies on the association between serum ferritin level and obesity [12] [13] [14] . However, these studies were cross-sectional and their sample size was small. Therefore, the associations might not have been fully understood.
Although the pathogenesis between serum ferritin levels and the development of obesity remains to be fully elucidated, chronic inflammatory reaction is considered to play an important role in the development and progression of obesity.
Obesity is considered to be a chronic inflammatory state and ferritin is a reactant that can be seen in the acute phase of inflammation [21] . In recent years, increased serum ferritin levels have been widely recognized to be a result of a chronic inflammatory reaction caused by obesity, and not just the result of an increase in iron stores [1] . Elevated serum ferritin levels may comprise an inflammatory state like that of MetS. Indeed, there are some evidences of a relevant relationship between serum ferritin levels and inflammation. For example, C-reactive protein, which is used as a surrogate marker for inflammation, has a relevant relationship with ferritin [22] . In addition, hepcidin, a peptide made in the liver, is elevated in response to hypoxia or inflammation [23] . Furthermore, it has been suggested that leptin seems to induce the expression of hepcidin via the JAK2/STAT3 pathway [24] . Further, hepcidin, which is a core modulator of iron metabolism, is correlated with increases in ferritin [25] .
However, in the present study, we demonstrated that elevated serum ferritin levels preceded obesity when obese participants (BMI ≥ 25 kg/m 2 ) were initially excluded. A recent study revealed that inflammatory cytokines may interact with MetS, obesity, insulin resistance, and type 2 diabetes mellitus [26] . In addition, it is well known that low adiponectin level is associated with obesity and MetS [27] . Wlazlo et al. showed that serum ferritin levels have an inverse association with adiponectin which was known one of major obesity-regulating hormone [28] . Gabrielsen
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nancy and female hormone replacement therapy, and serum ferritin levels differ significantly according to sex. Mean serum ferritin levels are generally lower in women than in men; this is probably attributable to menstrual iron loss in women. Thus, our results cannot be extrapolated to women, and further studies are necessary [33] . Although there have been several reports about the relationship between serum ferritin levels and metabolic syndrome [3, 4, 6, 22] , there has been no direct evidence whether serum ferritin is a predictor of development of obesity or not. Therefore, our study is meaningful to provide direct evidence to clarify the longitudinal relationship between serum ferritin levels and the development of obesity. 
